Siemens Healthineers


Q4 profitability missed and FY2027 guidance was below expectations

05/11/26 -"Siemens Healthineers’ Q4 profitability declined and was below market expectations. 2027 guidance also fell short of expectations. We will lower our estimates. The separation from Siemens in 2027 is ..."

Pages
74
Language
English
Published on
05/11/26
You may also be interested by these reports :
05/11/26
Siemens Healthineers’ Q4 profitability declined and was below market expectations. 2027 guidance also fell short of expectations. We will lower our ...

05/11/26
Tecan’s 3Q sales growth accelerated to 6.9% (LC), well above the 3.4% run rate of 1H26, with both segments contributing to the performance. ...

05/11/26
The strong 3Q print, combined with a positive FX effect, leads us to raise our 2026 sales estimate by c. 1.9%, which feeds through to our 2027 (c. ...

05/11/26
GN’s Q3 sales met market expectations, while profitability exceeded expectations, largely driven by tariff refunds. 2026 guidance was unchanged. ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO